FDA Advisors Lean Into Modifying COVID-19 Vaccines to Be Omicron-Specific

June 29, 2022 by Alexa Hornbeck
FDA Advisors Lean Into Modifying COVID-19 Vaccines to Be Omicron-Specific
This Thursday, Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. (Associated Press)

Key advisors from the U.S. Food and Drug Administration met on Tuesday to examine COVID-19 vaccines and whether there is need for modification as protection wanes.

During the Vaccines and Related Biological Products Advisory Committee meeting, a majority of the panel, 19-2, ruled in favor of manufacturing an omicron-containing booster, specifically targeting the BA.4 and BA.5 variants.

There were also considerations for creating a bivalent vaccine that would contain omicron and the original SARS-CoV-2 strain. 

The use of Novavax, a protein-based, non-mRNA vaccine that has not yet received an emergency use authorization from the FDA, was also discussed as a potential future booster. 

Some of the advisors examined whether the vaccine might work better at fighting against omicron infection as it includes an adjuvant that may not require revisions with emerging COVID-19 variants. 

How quickly manufacturers could revise the vaccine formula to target omicron was also discussed. Pfizer indicated it could have such a vaccine product available by the first week of October, and Moderna by late October or early November. 

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

March 27, 2024
by Dan McCue
One-Time Treatment Could Revitalize Immune Systems in the Elderly

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

March 27, 2024
by Dan McCue
Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

Five Takeaways From the Abortion Pill Case Before US Supreme Court

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

March 26, 2024
by Tom Ramstack
Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

News From The Well
scroll top